On the recordMarch 12, 2014
We don't want to, in any way, legislate what FDA should approve. But we want to get a more transparent and a more effective system of evaluating these important ingredients for this terrible cancer.
Source
congress.govEditor's note · Context
Isakson emphasizes the need for transparency in FDA evaluations for skin care ingredients.
Share & report
More from Johnny Isakson
Mar 7, 2019
Madam President, I ask unanimous consent to speak for 60 seconds. The PRESIDING OFFICER. Is there objection? Without objection, it is so ordered.
Apr 1, 2019
I don't want to cut anybody out, but I want to make that point. I yield to Senator Shelby. The PRESIDING OFFICER (Mr. Crapo). The Senator from Alabama.
Feb 7, 2019
Mr. President, the Committee on Veterans' Affairs has adopted rules governing its procedures for the 116th Congress. Pursuant to rule XXVI, paragraph 2, of the Standing Rules of the Senate, on behalf of myself and Senator Tester, I ask…
Mar 25, 2019
Thank you, Mr. President. I rise for a moment to talk about a vote we will have tomorrow in this Chamber on a motion to adopt an amendment to the supplemental appropriations passed by the House, and it is a disaster amendment dealing with…
Other voices in this conversation
